carbostyril has been researched along with AIDS Dementia Complex in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lisi, L; Miscioscia, FT; Navarra, P; Pizzoferrato, M; Topai, A | 1 |
| Delobel, P; Gandia, P; Guerveno, C; Izopet, J; Martin-Blondel, G; Metsu, D; Raymond, S | 1 |
2 other study(ies) available for carbostyril and AIDS Dementia Complex
| Article | Year |
|---|---|
Interactions between integrase inhibitors and human arginase 1.
Topics: AIDS Dementia Complex; Arginase; Cell-Free System; Cells, Cultured; Heterocyclic Compounds, 3-Ring; HIV Integrase Inhibitors; Humans; Microglia; Molecular Docking Simulation; Oxazines; Piperazines; Pyridones; Quinolones; Raltegravir Potassium | 2017 |
HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy.
Topics: AIDS Dementia Complex; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Brain; Central Nervous System; Cerebrospinal Fluid; Female; HIV-1; Humans; Magnetic Resonance Imaging; Middle Aged; Plasma; Quinolones; Viral Load | 2019 |